Webservice

International Eosinophil Society (IES) – Webinar on January 31^st

Save the date: Next joint EMBRN – IES webinar takes place on January 31st, 3.30 pm through 5 pm. Registration information will follow shortly.

November 7, 2023

New position at Genoskin as “Head of mast cell platform”

We have opened a new position at Genoskin as “Head of mast cell platform” at the level PhD/postdoc. Genoskin is a fast growing biotech company based in Toulouse, France and Boston (USA), and specialized in the testing of pharmaceutical molecules and de-risking of clinical trials. If

November 2, 2023

Mast cell silencing: a novel therapeutic approach for urticarial and other mast cell-mediated diseases

Summary Chronic urticaria (CU) is a mast cell (MC)-dependent disease with limited therapeutic options. Current management strategies are directed at inhibiting IgE-mediated activation of MCs and antagonizing effects of released mediators. Due to the complexity and heterogeneity of CU and other MC diseases and mechanisms

August 25, 2023

2B4 – A potential target in Staphylococcus aureus associated allergic inflammation

Summary Staphylococcus aureus (SA) and its exotoxins activate eosinophils (Eos) and mast cells (MCs) via CD48, a GPI-anchored receptor belonging to the Signaling Lymphocytes Activation Molecules (SLAM) family. 2B4 (CD244), an immuno-regulatory transmembrane receptor also belonging to the SLAM family, is the high affinity ligand for

August 25, 2023

A memorial tribute to K. Frank Austen: the father of Mast Cell Biology

K. Frank Austen, a remarkable, dedicated mast cell scientist and mentor over almost seven decades, passed away on June 23rd at an age of 95 years. Frank will be remembered as an immensely talented, focused and hardworking man who dedicated his whole adult life to

June 27, 2023

Joint EMBRN – EHRS webinar on Wednesday, May 31st, 2023

Dear EMBRN community, We are pleased to invite you to the Joint EMBRN – EHRS webinar that will take place at 14.30-16.00 CEST (Berlin, Paris, Amsterdam, Milano), on Wednesday, May 31st, 2023.(European Mast Cell and Basophil Research Network and European Histamine Research Society) Agenda 5’

May 19, 2023

Announcement of COST training school in Uppsala Feb. 23-26 2015

“Identification of biological and pharmaceutical mast cell and basophil related targets (WG3)” We like to welcome PhD-students and post-docs to the 3rd COST BM1007 training school on the ‘Identification of biological and pharmaceutical mast cell and basophil related targets’ February 23-26 in Uppsala, Sweden. The

October 30, 2022

Postdoctoral position available in mast cell biology and therapeutic at Imagine Institute-Paris-France

Offer: The laboratory of Dr Gaël Ménasché at Imagine Institute (https://www.institutimagine.org/en/gael-menasche-et-fernando-sepulveda-188) is looking for a full-time Postdoctoral Research Fellow to take on an exciting translational project aimed to develop new therapeutic strategies for allergic diseases. The position is offered for one year with the possibility

September 7, 2022

Excellence Fellowship Program for International Postdoctoral Researchers

The Israel Academy of Sciences and Humanities established a prestigious program in 2018 to bring outstanding post-docs from around the world to Israel’s research universities. The Israel Young Academy led by Prof. Yonina Eldar, suggested this as a solution to the need to strengthen research

August 19, 2022

2023 IES Biennial Symposium

International Eosinophil Society – Biennial Symposium – 11-15 July 2023